Covered recipient · General Payments record
SHAFIA RUBEEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,216.77
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $524.34 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $207.12 | 16 |
| PFIZER INC. | $60.28 | 3 |
| Novo Nordisk AS | $45.21 | 3 |
| DEXCOM, INC. | $37.53 | 2 |
| Amgen Inc. | $30.93 | 2 |
| Vanda Pharmaceuticals Inc. | $24.16 | 1 |
| Abbott Laboratories | $20.76 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.96 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.01 | 1 |
| Astellas Pharma US Inc | $17.68 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.30 | 1 |
| Cepheid | $13.23 | 1 |
| GlaxoSmithKline, LLC. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.76 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125315998 | CMS |
| ABBVIE INC. | $14.57 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983713 | CMS |
| ABBVIE INC. | $19.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983715 | CMS |
| ABBVIE INC. | $12.72 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983717 | CMS |
| ABBVIE INC. | $3.27 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983719 | CMS |
| ABBVIE INC. | $22.05 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983721 | CMS |
| ABBVIE INC. | $1.73 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983723 | CMS |
| ABBVIE INC. | $2.27 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983725 | CMS |
| ABBVIE INC. | $12.58 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983727 | CMS |
| ABBVIE INC. | $10.28 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983729 | CMS |
| ABBVIE INC. | $23.96 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983731 | CMS |
| ABBVIE INC. | $17.43 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983733 | CMS |
| ABBVIE INC. | $6.90 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983735 | CMS |
| ABBVIE INC. | $25.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983737 | CMS |
| ABBVIE INC. | $5.96 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983739 | CMS |
| ABBVIE INC. | $8.60 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983741 | CMS |
| ABBVIE INC. | $19.41 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983743 | CMS |
| Amgen Inc. | $15.22 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116071793 | CMS |
| Amgen Inc. | $15.71 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117671037 | CMS |
| Astellas Pharma US Inc | $17.68 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139363273 | CMS |
| Cepheid | $13.23 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128534452 | CMS |
| Dexcom, Inc. | $14.72 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335427 | CMS |
| Dexcom, Inc. | $22.81 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153335429 | CMS |
| GlaxoSmithKline, LLC. | $13.17 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116171483 | CMS |
| Novartis Pharmaceuticals Corporation | $17.30 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087303661 | CMS |
| Novo Nordisk Inc | $13.12 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096849023 | CMS |
| Novo Nordisk Inc | $13.41 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096811602 | CMS |
| Novo Nordisk Inc | $18.68 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096927040 | CMS |
| PFIZER INC. | $20.56 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130939546 | CMS |
| PFIZER INC. | $20.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131770134 | CMS |
| PFIZER INC. | $19.72 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131942005 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.01 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151118247 | CMS |
| Vanda Pharmaceuticals Inc. | $24.16 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133918661 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613108 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.